A biochemical definition of cure after brachytherapy for prostate cancer-Reference-Cited by-同舟云学术

A biochemical definition of cure after brachytherapy for prostate cancer

Published:2020-08 Issue: Volume:149 Page:64-69
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Crook Juanita M.^ORCID,Tang Chad,Thames Howard,Blanchard Pierre,Sanders Jeremiah^ORCID,Ciezki Jay,Keyes Mira,Morris W. James,Merrick Gregory^ORCID,Catton Charles^ORCID,Raziee Hamid^ORCID,Stock Richard,Sullivan Frank^ORCID,Anscher Mitch,Millar Jeremy,Frank Steven

Funder

National Cancer Institute

University of Texas MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference22 articles.

1. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37(5):1035-41.

2. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference;Roach;Int J Radiat Oncol Biol Phys,2006

3. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995;Thames;Int J Radiat Oncol Biol Phys,2003

4. Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: efficacy, toxicity, and quality of life outcomes;Frank;Int J Radiat Oncol Biol Phys,2018

5. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities;Brachytherapy;2024-09

2. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update;Radiotherapy and Oncology;2024-09

3. The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer;Biomedicines;2024-05-08

4. Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up;Brachytherapy;2024-05

5. Prostate Cancer;Geriatric Medicine;2024